Lantern Pharma, is a pharmaceutical company that uses AI and ML to rescue “failed” cancer drugs. The clinical-stage pharmaceutical company is developing new classes of precision cancer drugs with novel mechanisms of action, and also rescuing or revitalizing abandoned or failed cancer drugs using machine learning techniques, genomic data, and precision oncology trials.
Lantern Pharma is a clinical-stage oncology-focused biotech that leverages Artificial Intelligence and Machine Learning to deeply understand and analyze genomic data to predict patient response to our portfolio of therapies. Lantern in-licenses and develops therapies using genomic data, machine learning, and computational biology modeling to identify the patient groups most likely to respond to a therapy, and to clarify the potential underlying mechanism(s) of action.
We embrace nascent technology. Emerging technologies can help transform the pace and insight of oncology drug development. We currently leverage Artificial Intelligence, Machine Learning, Cloud Computing, and Large Scale Genomic & Transcriptomic Data. These techniques and methods have been robustly tested in many different industries and applying them to healthcare will help solve two of the central problems in cancer therapy:
1) Stratifying patients into responders and non-responders, ultimately de-risking and streamlining clinical trials
2) Clarifying insight into the mechanism of action for drugs, resulting in improved molecular targeting.
Both of these problems have great potential to be improved through the application of A.I., which helps to shorten the drug development timeline and reduce costs. We are continuously advancing our precision oncology therapeutics platform through partnerships with cloud computing firms, cancer research centers, clinical healthcare centers, other pharma and biotech companies, investigator consortia, and tissue and data banks.
I invited Panna Sharma, Chief Executive Officer, and President of Lantern Pharma onto my daily tech podcast to learn more about how much of a critical role technology is and will continue to play in the fight against cancer.
Subscribe to the Tech Talks Daily Podcast